ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,864.67
      0.40%
      US Tech 100
      19,783.20
      0.68%
      Dow Jones
      43,275.91
      0.09%
      Brent Oil
      72.935
      0.00%
      Bitcoin
      68,407.74
      0.07%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Verve Therapeutics Inc (VERV) Quote

      Verve Therapeutics Inc

      Verve Therapeutics Inc (VERV)

      Verbund Ag
      Verbund Ag
      Verbund Ag
      Verbund Ag
      5.65
      0.19
      (3.48%)
      Closed October 19 4:00PM
      Delayed by 15 minutes
      5.60
      -0.05
      (-0.88%)
      After Hours: 6:55PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      5.60
      Bid
      5.60
      Ask
      5.66
      Volume
      586,458
      5.39 Day's Range 5.735
      4.305 52 Week Range 20.12
      Market Cap
      473.897M
      Previous Close
      5.46
      Open
      5.47
      Last Trade
      10
      @
      5.61
      Last Trade Time
      Financial Volume
      $ 3,279,261
      VWAP
      5.5916
      Average Volume (3m)
      1,353,597
      Shares Outstanding
      84,624,529
      Dividend Yield
      -
      PE Ratio
      -2.39
      Earnings Per Share (EPS)
      -2.36
      Revenue
      11.76M
      Net Profit
      -200.07M

      About Verve Therapeutics Inc

      Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively... Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.vervetx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Verve Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VERV. The last closing price for Verve Therapeutics was $5.46. Over the last year, Verve Therapeutics shares have traded in a share price range of $ 4.305 to $ 20.12.

      Verve Therapeutics currently has 84,624,529 shares outstanding. The market capitalization of Verve Therapeutics is $462.05 million. Verve Therapeutics has a price to earnings ratio (PE ratio) of -2.39.

      Ask ADVFN Intelligence (AI)

      VERV Latest News

      More News

      Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERV

      Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERV PR...

      October 17 2024
      PR Newswire (US)

      Class Action Filed Against Verve Therapeutics, Inc. (VERV) - October 28, 2024 Deadline to Join - Contact The Gross Law Firm

      Class Action Filed Against Verve Therapeutics, Inc. (VERV) - October 28, 2024 Deadline to Join - Contact The Gross Law Firm PR Newswire NEW YORK, Oct. 14, 2024 NEW YORK, Oct. 14, 2024...

      October 14 2024
      PR Newswire (US)

      The Gross Law Firm Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming Deadline

      The Gross Law Firm Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, Oct. 10, 2024 NEW YORK, Oct. 10, 2024...

      October 10 2024
      PR Newswire (US)

      Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERV

      Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERV PR...

      October 07 2024
      PR Newswire (US)

      Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on September...

      October 02 2024
      GlobeNewswire Inc.

      Verve Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VERV

      Verve Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VERV PR Newswire LOS ANGELES, Oct. 2, 2024 LOS ANGELES, Oct. 2, 2024 /PRNewswire/...

      October 02 2024
      PR Newswire (US)

      Investors in Verve Therapeutics, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - VERV

      Investors in Verve Therapeutics, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - VERV PR Newswire NEW YORK, Sept. 30, 2024 NEW YORK, Sept. 30, 2024...

      September 30 2024
      PR Newswire (US)

      Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERV

      Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERV PR...

      September 26 2024
      PR Newswire (US)

      The Gross Law Firm Reminds Verve Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERV

      The Gross Law Firm Reminds Verve Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERV PR Newswire NEW YORK, Sept. 23, 2024...

      September 23 2024
      PR Newswire (US)

      The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Verve Therapeutics Lawsuit - VERV

      The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2024 in Verve Therapeutics Lawsuit - VERV PR Newswire NEW YORK, Sept. 19, 2024 NEW YORK, Sept. 19, 2024...

      September 19 2024
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.9921.47505422994.615.8554.519910681075.31715773CS
      40.285.263157894745.325.8554.3911786004.97018825CS
      12-2.13-27.55498059517.737.94.30513535975.36575705CS
      26-1.14-16.91394658756.747.964.30513550515.64818995CS
      52-5.85-51.091703056811.4520.124.30514302039.0419704CS
      156-38-87.155963302843.656.184.30598882216.66761574CS
      260-24.4-81.333333333330784.30593616718.50358873CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DRUGBright Minds Biosciences Inc
      $ 47.37
      (118.29%)
      		27.24M
      BIVIBioVie Inc
      $ 2.3304
      (108.07%)
      		52.3M
      HEPSD Market Electronic Services and Trading
      $ 3.52
      (60.00%)
      		43.86M
      LTBRLightbridge Corporation
      $ 6.98
      (56.85%)
      		7.72M
      PEGYPineapple Energy Inc
      $ 8.19
      (48.64%)
      		31.69M
      NKGNNKGen Biotech Inc
      $ 0.3974
      (-43.23%)
      		5.06M
      ORGSOrgenesis Inc
      $ 2.1001
      (-35.14%)
      		486.29k
      BIAFbioAffinity Technologies Inc
      $ 1.40
      (-34.27%)
      		1.45M
      VEVVicinity Motor Corporation
      $ 0.0466
      (-31.27%)
      		37.52M
      CETXCemtrex Inc
      $ 0.299
      (-27.07%)
      		20.69M
      JTAIJet AI Inc
      $ 0.1008
      (4.02%)
      		347.49M
      NVDANVIDIA Corporation
      $ 138.00
      (0.78%)
      		175.79M
      SQQQProShares UltraPro Short QQQ
      $ 7.13
      (-1.79%)
      		105.78M
      TVGNTevogen Bio Holdings Inc
      $ 1.72
      (24.64%)
      		101.27M
      LCIDLucid Group Inc
      $ 2.625
      (-2.42%)
      		80.88M

      VERV Discussion

      View Posts
      Monksdream Monksdream 2 months ago
      VERV new 52 week low
      👍️0
      Monksdream Monksdream 2 months ago
      VERV new 52 week low
      👍️0
      Monksdream Monksdream 3 months ago
      VERV 10Q due AUGUST5
      👍️0
      Monksdream Monksdream 4 months ago
      VERV new 52 week low
      👍️0
      Monksdream Monksdream 4 months ago
      VERV new 52 week low
      👍️0
      Monksdream Monksdream 5 months ago
      VERV more new lows up ahead
      👍️0
      Monksdream Monksdream 5 months ago
      VERV new 52 week low
      👍️0
      Monksdream Monksdream 6 months ago
      VERV new 52 week low
      👍️0
      Monksdream Monksdream 6 months ago
      VERV new 52 week low
      👍️0
      Monksdream Monksdream 6 months ago
      VERV new 52 week low
      👍️0
      Monksdream Monksdream 6 months ago
      VERV new 52 lo
      👍️0
      Firestorm22 Firestorm22 7 months ago
      uh oh
      👍️0
      Monksdream Monksdream 7 months ago
      VERV over $10
      👍️0
      fink fink 8 months ago
      Looking for an entry now
      👍️0
      Terpi Terpi 11 months ago
      Could see another nice move here is the 50 day holds into close.
      👍️0
      Monksdream Monksdream 12 months ago
      VERV morning rally
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      https://cathiesark.com/
      👍️0
      crudeoil24 crudeoil24 2 years ago
      VERV IS A GREAT $$$$$ OPPORTUNITY.
      👍️0
      crudeoil24 crudeoil24 2 years ago
      Verve Therapeutics started at outperform with $48 stock price target at BMO Capital
      👍️0
      crudeoil24 crudeoil24 2 years ago
      Verve Therapeutics, Inc. is a genetic medicines company, developing an approach to the care of cardiovascular disease (CVD) transforming treatment from chronic management to single-course gene editing medicines. The Company’s initial two programs target PCSK9 and ANGPTL3, respectively, genes that regulate levels of blood lipids. Its lead product candidate, VERVE-101, is designed to permanently turn off the PCSK9 gene in the liver. Reduction of PCSK9 protein in the blood improves the ability of the liver to clear LDL-C from the blood. VERVE-101 utilizes LNP-mediated delivery to target the liver and base editing technology to make a single base change at a specific site in the PCSK9 gene in order to disrupt PCSK9 protein production. It is advancing VERVE-101 initially for the treatment of heterozygous familial hypercholesterolemia. Its second program is designed to permanently turn off the ANGPTL3 gene in the liver. ANGPTL3 is a key regulator of cholesterol and triglyceride metabolism.
      👍️0

      Your Recent History

      NASDAQ
      VERV
      Verve Therapeutics
      BIT
      F08436
      Vontobel Financial Produ...
      Delayed Upgrade Clock